Histology and Cytology Market Analysis By Type of Examination (Cytology [Cervical Cancer, Breast Cancer, Others], Histology), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2014 - 2025

  • ID: 4312549
  • Report
  • Region: America, Asia, Asia Pacific, Europe, North America, United States
  • 80 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • Sysmex Corporation
  • MORE
The global histology and cytology market size is expected to reach USD 26.9 billion by 2025. Globally, the increasing incidence of cancer and growing adoption of cytological tests due to its less invasive nature as compared to biopsy & higher reliability are likely to drive the market during the forecast period.

Furthermore, rising well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect the market growth. Advancements in the cytology and histology save the time for pathologists, hence this makes the service more cost-effective.

Cytology was the largest segment in the histology and cytology market in 2016 and is expected to maintain its dominance during the forecast period due to the recent entry of various tests for cytological testing and advantages over histology such as faster analysis and economical technique.

Cytology is further segmented into cervical, breast, and other cancers based on its application. Cervical cancer segment dominated in 2016 due to higher incidence and growing demand of test for the cervical cancer screening. Furthermore, breast cancer was considered as the second largest segment due to rising awareness about breast cancer screening in emerging countries.

Further Key Findings From the Report Suggest:
  • Rising incidence of cancer and growing investment by players are expected to propel growth at the fastest rate with a CAGR of 13.5% from 2017 to 2025
  • Cytology testing segment dominated in 2016 and is estimated to account for majority of the share by 2025.
  • Cytological testing for cervix is the largest contributing segment of the market. This can be attributed to high incidence and more adoption of the test for cervix screening.
  • The U.S. market was the largest in 2016 and is expected to maintain its dominance during forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries.
  • In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves the detection of cervical precancer.
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and increasing adoption of screening tests.
  • Some of the key players operating are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • Sysmex Corporation
  • MORE
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
2. Executive Summary
2.1. Market Snapshot
3. Histology and Cytology Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2014 - 2025
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. PESTEL Analysis, 2015
3.7. Histology and Cytology Competitive Scenario, 2016
3.7.1. Competitive landscape/Heat map analysis: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
4. Histology and Cytology Market: Type of Examination Outlook
4.1. Histology and Cytology Market Share by Test, 2016& 2025 (USD Million)
4.2. Cytology
4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.2.3. Cervical Cancer
4.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.2.4. Breast Cancer
4.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.2.5. Other Cancers
4.2.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
4.3. Histology
4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
5. Histology and Cytology Market: Regional Outlook
5.1. Histology and Cytology Market Share by Region, 2016 & 2025 (USD Million)
5.2. North America
5.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.2.3. U.S.
5.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.2.4. Canada
5.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.3. Europe
5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.3.3. Germany
5.3.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.3.4. U.K.
5.3.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.4.3. China
5.4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.4.4. Japan
5.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.5. Central & South America
5.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.5.3. Brazil
5.5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.5.4. Mexico
5.5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.6. Middle East & Africa
5.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.6.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
5.6.3. South Africa
5.6.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.6.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
6. Competitive Landscape
6.1. Competitive Environment
6.2. Strategy Framework
7. Company Profiles
7.1. Becton Dickinson and Company
7.1.1. Company overview
7.1.2. Financial performance
7.1.3. Industries and services catered
7.1.4. Product benchmarking
7.1.5. Strategic initiatives
7.2. F. Hoffmann-La Roche Ltd.
7.2.1. Company overview
7.2.2. Financial performance
7.2.3. Industries and services catered
7.2.4. Product benchmarking
7.2.5. Strategic initiatives
7.3. Abbott Laboratories
7.3.1. Company overview
7.3.2. Financial performance
7.3.3. Industries and services catered
7.3.4. Product benchmarking
7.3.5. Strategic initiatives
7.4. Hologic, Inc.
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Industries and services catered
7.4.4. Product benchmarking
7.4.5. Strategic initiatives
7.5. Thermo Fisher Scientific
7.5.1. Company overview
7.5.2. Financial performance
7.5.3. Industries and services catered
7.5.4. Product benchmarking
7.5.5. Strategic initiatives
7.6. Danaher Corporation
7.6.1. Company overview
7.6.2. Financial performance
7.6.3. Industries and services catered
7.6.4. Product benchmarking
7.6.5. Strategic initiatives
7.7. Sysmex Corporation
7.7.1. Company overview
7.7.2. Financial performance
7.7.3. Industries and services catered
7.7.4. Product benchmarking
7.7.5. Strategic initiatives
7.8. Trivitron Healthcare
7.8.1. Company overview
7.8.2. Financial performance
7.8.3. Industries and services catered
7.8.4. Product benchmarking
7.8.5. Strategic initiatives
7.9. Merck KGaA
7.9.1. Company overview
7.9.2. Financial performance
7.9.3. Industries and services catered
7.9.4. Product benchmarking
7.9.5. Strategic initiatives

List of Tables

Table 1 Histology and cytologymarket estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 2 Histology and cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
Table 3 Cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
Table 4 Histology market estimates and forecast by region, 2014 - 2025 (USD Million)
Table 5 Histology and cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
Table 6 North America histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 7 North America histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 8 U.S. histology and cytology market estimates and forecast by type of examination, (USD Million)
Table 9 Canada histology and cytology market estimates and forecast by type of examination, (USD Million)
Table 10 Europe histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 11 Europe histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 12 Germany histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 13 U.K. histology and cytology market estimates and forecast by type of examination, (USD Million)
Table 14 Asia Pacific histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 15 Asia Pacific histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 16 China histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 17 Japan histology and cytology market estimates and forecast by type of examination, (USD Million)
Table 18 Central & South America histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 19 Central & South America histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 20 Brazil histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 21 Mexico histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 22 Middle East & Africa histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 23 Middle East & Africa histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
Table 24 South Africa histology and cytology market estimates and forecast by type of examination, (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing &forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Histology and cytology market summary 2016, (USD Million)
Figure 8 Market trends & outlook
Figure 9 Market segmentation& scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market restraint relevance analysis (Current & future impact)
Figure 12 Penetration & growth prospect mapping
Figure 13 SWOT Analysis, by factor (political & legal, economic and technological)
Figure 14 Porter’s Five Forces analysis
Figure 15 Histology and cytology competitive landscape: Market position analysis (based on tests, regional presence)
Figure 16 Histology and cytology market, type of examination outlook key takeaways
Figure 17 Histology and cytology: Type of examination movement analysis
Figure 18 Cytology market, 2014 - 2025 (USD Million)
Figure 19 Cervical cancer market, 2014 - 2025 (USD Million)
Figure 20 Breast cancers Market, 2014 - 2025 (USD Million)
Figure 21 Other cancers market, 2014 - 2025 (USD Million)
Figure 22 Histology market, 2014 - 2024 (USD Million)
Figure 23 Regional market place: Key takeaways
Figure 24 Histology and cytology market: Regional movement analysis
Figure 25 North America histology and cytology market, 2014 - 2025 (USD Million)
Figure 26 The U.S. histology and cytology market, 2014 - 2025 (USD Million)
Figure 27 Canada histology and cytology market, 2014 - 2025 (USD Million)
Figure 28 Europe histology and cytology market, 2014 - 2025 (USD Million)
Figure 29 The U.K. histology and cytology market, 2014 - 2025 (USD Million)
Figure 30 Germany histology and cytology market, 2014 - 2025 (USD Million)
Figure 31 Asia Pacific histology and cytology market, 2014 - 2025 (USD Million)
Figure 32 China histology and cytology market, 2014 - 2025 (USD Million)
Figure 33 Japan histology and cytology market, 2014 - 2025 (USD Million)
Figure 34 Central and South America histology and cytology market, 2014 - 2025 (USD Million)
Figure 35 Brazil histology and cytology market, 2014 - 2025 (USD Million)
Figure 36 Mexico histology and cytology market, 2014 - 2025 (USD Million)
Figure 37 MEA histology and cytology market, 2014 - 2025 (USD Million)
Figure 38 South Africa histology and cytology market, 2014 - 2025 (USD Million)
Figure 39 Competitive strategy adopted by leading players
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Hologic, Inc.
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Sysmex Corporation
  • Trivitron Healthcare
  • Merck KGaA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll